Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom.

Russell, Mark D; Rutherford, Andrew I; Ellis, Benjamin; Norton, Sam; Douiri, Abdel; Gulliford, Martin C; Cope, Andrew P; Galloway, James B

Russell, Mark D; Rutherford, Andrew I; Ellis, Benjamin; Norton, Sam; Douiri, Abdel; Gulliford, Martin C; Cope, Andrew P; Galloway, James B.

Afiliación

Russell MD; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Rutherford AI; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, SE5 9RS, UK.
Ellis B; Department of Rheumatology, Imperial College Healthcare NHS Foundation Trust, London.
Norton S; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Douiri A; School of Population Health and Environmental Sciences, King's College London, SE1 1UL, UK.
Gulliford MC; School of Population Health and Environmental Sciences, King's College London, SE1 1UL, UK.
Cope AP; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.

Lancet Reg Health Eur ; 18: 100416, 2022 Jul.

Article en En | MEDLINE | ID: mdl-35814340

Palabras clave

Allopurinol; Crystal arthritis; Epidemiology; Gout; Treat-to-target; Urate-lowering therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Lancet Reg Health Eur Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google